Ex-pharma CEO Shkreli is getting new lawyers

The House Committee on Oversight and Government Reform, which has been investigating the price increases undertaken by Turing and other drug companies, has subpoenaed Mr. Shkreli and ordered him to testify at a hearing scheduled for Tuesday on drug-price increases. However, the judge in the case could grant an exception to travel.

Shkreli, who created a firestorm previous year for raising the price of a lifesaving medicine by more than 5,000 percent, is separately facing federal criminal charges that he defrauded investors.

Yes, Pharma Bro is a legitimate demon who actively tried to harm thousands and thousands of innocent people, and you’d be quite right in wondering why the Catholic Church hasn’t been called in to banish him from our plane of existence.

Rep. Elijah Cummings, D-Maryland, said Shkreli has apparently not made any legal arrangements to travel to Washington, based on conversations with his attorney. Shkreli has invoked his Fifth Amendment privilege against self-incrimination and has refused to submit documents demanded by the Senate’s Special Committee on Aging in a separate subpoena.

Under increasing scrutiny of powerful government authorities, former Turing Pharmaceuticals CEO Martin Shkreli lashed out at his opponents on Twitter. He resigned as CEO of Turing, which he founded and ran. “Found this letter, looks important”, he tweeted with a photo of the request.

New York-based Turing confirmed that its chief commercial officer, Nancy Retzlaff, will testify at the hearing next week.

The House committee issued the demand January 11 under chairman Jason Chaffetz, R-Utah, according to a copy obtained by the Associated Press on Wednesday.

“We will be relentlessly focused on providing easy and affordable access for physicians and patients”, he said, elaborating that Valeant will shift to more of an R&D focus in 2016 and avoid exorbitant price hikes in certain therapeutic portfolios.

Shkreli has also drawn the ire of Senate lawmakers. “The Committee expects him to comply with that subpoena”.

Both senators said he was improperly asserting his Fifth Amendment rights, given their inquiry into his company’s pharmaceutical business ostensibly doesn’t have anything to do with his securities fraud case.